Cited by 548Ubiquitin and proteasome pathwaysCancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network

Open access

Song, Min Sup, Salmena, Leonardo, Carracedo, Arkaitz, Egia, Ainara, Lo-Coco, Francesco, Teruya-Feldstein, Julie, Pandolfi, Pier Paolo·2008·Nature

DOI 10.1038/nature07290PMC PMC3398484

Open this paper in CoChat — free account

Abstract

Nuclear exclusion of the PTEN (phosphatase and tensin homologue deleted in chromosome 10) tumour suppressor has been associated with cancer progression. However, the mechanisms leading to this aberrant PTEN localization in human cancers are currently unknown. We have previously reported that ubiquitinylation of PTEN at specific lysine residues regulates its nuclear-cytoplasmic partitioning. Here we show that functional promyelocytic leukaemia protein (PML) nuclear bodies co-ordinate PTEN localization by opposing the action of a previously unknown PTEN-deubiquitinylating enzyme, herpesvirus-associated ubiquitin-specific protease (HAUSP, also known as USP7), and that the integrity of this molecular framework is required for PTEN to be able to enter the nucleus. We find that PTEN is aberrantly localized in acute promyelocytic leukaemia, in which PML function is disrupted by the PML-RARalpha fusion oncoprotein. Remarkably, treatment with drugs that trigger PML-RARalpha degradation, such as all-trans retinoic acid or arsenic trioxide, restore nuclear PTEN. We demonstrate that PML opposes the activity of HAUSP towards PTEN through a mechanism involving the adaptor protein DAXX (death domain-associated protein). In support of this paradigm, we show that HAUSP is overexpressed in human prostate cancer and is associated with PTEN nuclear exclusion. Thus, our results delineate a previously unknown PML-DAXX-HAUSP molecular network controlling PTEN deubiquitinylation and trafficking, which is perturbed by oncogenic cues in human cancer, in turn defining a new deubiquitinylation-dependent model for PTEN subcellular compartmentalization.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature07290

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Sundaram, S. K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T. R., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,719
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Tenets of PTEN Tumor Suppression
Salmena, L., Carracedo, A., & Pandolfi, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.04.013 · Cited by 1,050
Self-citation
Essential role for nuclear PTEN in maintaining chromosomal integrity
Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., & Yin, Y. (2007) · Cell · doi:10.1016/j.cell.2006.11.042 · Cited by 979
Self-citation
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
Bernardi, R., & Pandolfi, P. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2277 · Cited by 876
Self-citation
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Tatham, M. H., Geoffroy, M., Shen, L., Plechanovová, A., Hattersley, N., Jaffray, E., Palvimo, J. J., & Hay, R. T. (2008) · Nature Cell Biology · doi:10.1038/ncb1716 · Cited by 837
Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W. (2003) · Science · doi:10.1126/science.1091362 · Cited by 804
PTEN: One Gene, Many Syndromes
Eng, C. (2003) · Human Mutation · doi:10.1002/humu.10257 · Cited by 787
Ubiquitination regulates PTEN nuclear import and tumor suppression
Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748
Self-citation

Show all 34 references

Sorted by citations

Items 401–500 of 546

USP49-Mediated Histone H2B Deubiquitination Regulates HCT116 Cell Proliferation through MDM2-p53 Axis
Shi, L., Shen, X., & Shen, Y. (2022) · Molecular and Cellular Biology · doi:10.1128/mcb.00434-21 · Cited by 10
Isopeptidases in anticancer therapy: looking for inhibitors.
Sgorbissa, A., Potu, H., & Brancolini, C. (2010) · PubMed Central · Cited by 9
Analyzing aggregation propensities of clinically relevant PTEN mutants: a new culprit in pathogenesis of cancer and other PTENopathies
Palumbo, E., Zhao, B., Xue, B., Uversky, V. N., & Davé, V. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1630005 · Cited by 9
USP7 protects TFEB from proteasome-mediated degradation
Keshri, S., Vicinanza, M., Takla, M., & Rubinsztein, D. C. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114872 · Cited by 8
Molecular mechanisms of PTEN in atherosclerosis: A comprehensive review
Tian, Y., Liu, Y., Wang, Y., Li, Y., Ding, W., & Zhang, C. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176857 · Cited by 8
Therapeutic inhibition of USP7 promotes antitumor immune responses
Muchowicz, A., Głuchowska, K., Grzybowski, M. M., Szostakowska-Rodzoś, M., Rejczak, T. P., Belczyk-Ciesielska, A., Wilk, M. M., Kikulska, A., Marzęta-Assas, P., Zagożdżon, A., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012287 · Cited by 8
Cytoplasmic Protein Tyrosine Kinases
Thiriet, M. (2012) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-1-4614-4370-4_4 · Cited by 8
In Silico Analysis of USP7 Inhibitors Based on Building QSAR Models and Fragment Design for Screening Marine Compound Libraries
Tan, H., Li, C., Lai, T., & Luo, L. (2023) · Marine Drugs · doi:10.3390/md22010001 · Cited by 8
Ubiquitin-Specific-Processing Protease 7 Regulates Female Germline Stem Cell Self-Renewal Through DNA Methylation
Zhao, Y., Li, X., Tian, G. G., Zhao, X., Wong, J., Shen, Y., & Wu, J. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10076-9 · Cited by 8
Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential
Guo, J., Xia, B.-R., Deng, S.-H., Yang, C. Q., Pi, Y., Cui, B., & Jin, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.680100 · Cited by 8
Semisynthetic Approach to the Analysis of Tumor Suppressor PTEN Ubiquitination
Iwase, R., Dempsey, D. R., Whedon, S. D., Jiang, H., Palanski, B. A., Deng, B., & Cole, P. A. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c13871 · Cited by 8
Thwarting PTEN Expression by siRNA Augments HL-60 Cell Differentiation to Neutrophil-Like Cells by DMSO and ATRA
Teimourian, S., & Moghanloo, E. (2016) · DNA and Cell Biology · doi:10.1089/dna.2016.3317 · Cited by 8
Guanosine Triphosphatases and Their Regulators
Thiriet, M. (2012) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-1-4614-4370-4_9 · Cited by 7
On the Prevalence and Roles of Proteins Undergoing Liquid–Liquid Phase Separation in the Biogenesis of PML-Bodies
Silonov, S. A., Mokin, Y. I., Nedelyaev, E. M., Smirnov, E. Y., Константинович, Т. К., Константинович, Т. К., Uversky, V. N., & Fonin, A. V. (2023) · Biomolecules · doi:10.3390/biom13121805 · Cited by 7
Resistance to Proteasome Inhibitors in Multiple Myeloma
Cottini, F., Guidetti, A., Prada, C. P., Hideshima, T., Maglio, M. E., Varga, C., Chauhan, D., Laubach, J. P., Anderson, K. C., & Richardson, P. G. G. (2014) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-06752-0_2 · Cited by 7
Proteasomal turnover of the RhoGAP tumor suppressor DLC1 is regulated by HECTD1 and USP7
Frey, Y., Franz‐Wachtel, M., Maček, B., & Olayioye, M. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-08844-3 · Cited by 7
The CTLH ubiquitin ligase substrates ZMYND19 and MKLN1 negatively regulate mTORC1 at the lysosomal membrane
Wang, Y., Liao, Y., Sun, Y., Mitra, B., Guo, R., Piedras, B. I., White, S., Tang, H.-Y., Asara, J. M., Tempera, I., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65760-6 · Cited by 7
USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and Tumorigenesis
Lusardi, M., Rapetti, F., Spallarossa, A., Massone, M., Cichero, E., & Brullo, C. (2025) · Molecules · doi:10.3390/molecules30204038 · Cited by 6
Understanding the Interactions of Ubiquitin-Specific Protease 7 with Its Substrates through Molecular Dynamics Simulations: Insights into the Role of Its C-Terminal Domains in Substrate Recognition
Velázquez‐Libera, J. L., Caballero, J., Alzate‐Morales, J. H., Ruiz‐Pernía, J. J., & Tuñón, I. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01971 · Cited by 6
Suppression of USP7 negatively regulates the stability of ETS proto-oncogene 2 protein
Park, H., Min, Y., Hwang, S., & Baek, K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114700 · Cited by 6
RETRACTED ARTICLE: Micafungin exerts antitumor effect on breast cancer and osteosarcoma through preventing EMT in tumor cells in an USP7/AKT/GSK-3β pathway-dependent manner
Wang, Q.-L., Wang, L., Li, Q.-Y., Li, H.-Y., Lin, L., Wei, D., Xu, J., & Luo, X. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02903-w · Cited by 6
Retracted
Role of Tumor Suppressor PTEN and Its Regulation in Malignant Transformation of Endometrium
Perevalova, A. M., Kobelev, V. S., Сисакян, В. Г., Gulyaeva, L. F., & Pustylnyak, V. O. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922110104 · Cited by 6
Nuclear-cytoplasmic Shuttling in Chronic Myeloid Leukemia: Implications in Leukemia Maintenance and Therapy
Carrà, G., Russo, I., Guerrasio, A., & Morotti, A. (2019) · Cells · doi:10.3390/cells8101248 · Cited by 6
Deubiquitinases and Cancer
Murali, P., Kavitha, B., & Narasimhan, M. (2024) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_517_24 · Cited by 6
Rational Computational Workflow for Structure-Guided Discovery of a Novel USP7 Inhibitor
Srivastava, M., Kumari, D., Majumder, S., Singh, N., Mathur, R., Maiti, T. K., Kumar, A., & Asthana, S. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01400 · Cited by 6
Functional spectrum of USP7 pathogenic variants in Hao–Fountain syndrome: Insights into the enzyme’s activity, stability, and allosteric modulation
Korchak, E. J., Sharafi, M., Maisonet, I. J., Salazar‐Chaparro, A. F., Semenova, I. V., Khan, H., O’Neil, A., Caro, P., Schaaf, C. P., Buhrlage, S. J., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2510252122 · Cited by 5
Insights into the Structural and Energetic Descriptions of Ubiquitin Specific Protease 7 (USP7) Catalytic Mechanisms by Hybrid QM/MM Simulations.
Velázquez‐Libera, J. L., Caballero, J., Alzate‐Morales, J. H., Ruiz‐Pernía, J. J., & Tuñón, I. (2023) · ChemCatChem · doi:10.1002/cctc.202300344 · Cited by 5
Multifunctional adaptor protein Daxx interacts with chromatin-remodelling ATPase Brg1
Švadlenka, J., Bražina, J., Hanzlíková, H., C̆ermák, L., & Anděra, L. (2015) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2015.12.012 · Cited by 5
The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia
Carrà, G., Panuzzo, C., Crivellaro, S., Morena, D., Taulli, R., Guerrasio, A., Saglio, G. N., & Morotti, A. (2016) · Oncology Letters · doi:10.3892/ol.2016.5073 · Cited by 5
PTEN in Prostate Cancer
Ruscetti, M. A., & Wu, H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6828-8_4 · Cited by 6
Mitogen-Activated Protein Kinase Module
Thiriet, M. (2012) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-1-4614-4370-4_6 · Cited by 5
Role of deubiquitylase HAUSP in stem cell maintenance
Huang, Z., Zhou, W., & Bao, S. (2011) · Cell Cycle · doi:10.4161/cc.10.8.15260 · Cited by 5
Rational DESIGN and Structure-activity relationship study of novel JOSD2 inhibitor against colorectal cancer
Liu, P., Guo, Y., Guo, R., Yuan, T., Lai, Y., Zhu, H., Zhang, Y., He, Q., & Pan, C. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109022 · Cited by 4
The Ubiquitin–Proteasome System in Brain Disorders: Pathogenic Pathways, Post-Translational Tweaks, and Therapeutic Frontiers
Gupta, R. V., Begum, M. Y., Kumar, R., Gupta, J., Nagraik, R., Panda, S. P., Abomughaid, M. M., Lakhanpal, S., Avinash, D., Osmani, R. A. M., et al. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10258-7 · Cited by 4
The Role of Deubiquitinating Enzymes in Primary Bone Cancer
Colaco, J. C., Suresh, B., Kaushal, K., Singh, V., & Ramakrishna, S. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01254-y · Cited by 4
Targeting the Ubiquitin Proteasome System in Cancer
Kumari, N., Lee, K. K., & Jha, S. (2018) · InTech eBooks · doi:10.5772/intechopen.76705 · Cited by 5
Essence of PTEN: a Broad-Spectrum Therapeutic Target in Cancer
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac112.95879603 · Cited by 4
1H, 13C and 15N backbone resonance assignment for the 40.5 kDa catalytic domain of Ubiquitin Specific Protease 7 (USP7)
Lello, P. D., Rougé, L., Pan, B., & Maurer, T. (2016) · Biomolecular NMR Assignments · doi:10.1007/s12104-016-9698-3 · Cited by 4
Role of Ubiquitin-specific Proteases in Hepatocellular Carcinoma Pathogenesis
Zhang, X., Jin, J., Cong, J., Chen, S., Wang, T., Gao, B., Huang, G., Huang, Z., Zhang, J., Wang, Z., et al. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266279228231219101233 · Cited by 4
Targeting Ubiquitin‐Specific Protease 7 with Novel 5‐Amino‐Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation
Lusardi, M., Morretta, E., Spallarossa, A., Monti, M. C., Rosano, C., Iervasi, E., Ponassi, M., Mori, M., Meneghetti, F., & Brullo, C. (2025) · ChemMedChem · doi:10.1002/cmdc.202500185 · Cited by 3
Targeting Ubiquitin-Specific Protease 7 (USP7): A Pharmacophore-Guided Drug Repurposing and Physics-Based Molecular Simulation Study
Kanan, D., Kanan, T., Doğan, B., Erol, İ., & Durdağı, S. (2025) · ACS Omega · doi:10.1021/acsomega.5c03150 · Cited by 3
A detrimental mutation on USP40 unlocks the tumorigenesis in a rare case of lung cancer.
Xu, Z., Wang, H., Ji, X., Zhang, F., Gao, B., Hu, J., & Zheng, J. (2019) · Europe PMC (PubMed Central) · Cited by 3
Organ defects of the Usp7 mutant mouse strain indicate the essential role of K63-polyubiquitinated Usp7 in organ formation
Wu, H., Lin, Y., Chew, S. H., & Wu, K. (2022) · Biomedical Journal · doi:10.1016/j.bj.2022.02.002 · Cited by 3
Implications of ubiquitination and the maintenance of replication fork stability in cancer therapy
Xia, D., Zhu, X., Wang, Y., Gong, P., Su, H.-S., & Xu, X. (2023) · Bioscience Reports · doi:10.1042/bsr20222591 · Cited by 3
Key roles of ubiquitination in regulating critical regulators of cancer stem cell functionality
Guo, Q., Qin, H., Chen, Z., Zhang, W., Zheng, L., & Qin, T. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101311 · Cited by 3
Deubiquitinating enzyme USP42 promotes breast cancer progression by inhibiting JNK/p38-mediated apoptosis
He, C., Chen, J., Tian, R., Liu, Y., He, W., He, L., Xu, J., Li, J., Wang, G., Jiang, C., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-20573-x · Cited by 3
Ubiquitin-specific proteases as targets for anticancer drug therapies
Campos-Iglesias, D., López-Otín, C., & Freije, J. M. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818168-3.00004-8 · Cited by 4
HAUSP Is a Key Epigenetic Regulator of the Chromatin Effector Proteins
Abdullah, O., & Alhosin, M. (2021) · Genes · doi:10.3390/genes13010042 · Cited by 3
HAUSP Stabilizes SOX2 through Deubiquitination to Maintain Self-renewal and Tumorigenic Potential of Glioma Stem CellsPreprint
Huang, Z., Zhai, K., Wu, Q., Fang, X., Huang, Q., Tao, W., Lathia, J. D., Yu, J. S., Rich, J. N., & Bao, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.09.447550 · Cited by 3
Discovery of indane and naphthalene derivatives as USP7 inhibitors
Zhang, X., Tan, S., Wang, D., Zhu, H., Chen, D., Chen, Y., Wu, G., Zhu, Z., Zhang, F., Li, X., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117824 · Cited by 2
Antagonistic Ubiquitin Switching by USP7 and RNF40 Orchestrates KDM6A Homeostasis to License Coronavirus Susceptibility
Huang, M. R., Yang, Z., Wang, S., Ge, Y., Lin, L., Alfajaro, M. M., Filler, R. B., Song, W., Kong, M., & Wei, J. (2026) · Advanced Science · doi:10.1002/advs.202518058 · Cited by 2
Development and validation of a fluorescence polarization-based assay for USP7: From probe design to inhibitor evaluation
Chen, S., Wang, M., Zeng, Y., Li, X., Zhong, H., Liu, Y., Tao, Y., Yang, X., Luo, C., Chen, S., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118857 · Cited by 2
Effects of deubiquitylases on the biological behaviors of neural stem cells
Zhao, Q., Li, Y., Du, X., Chen, X., Jiao, Q., & Jiang, H. F. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22844 · Cited by 2
Recent Progress of Ubiquitin-Specific-Processing Protease 7 Inhibitors
Chi, L., Wang, H., Yu, F., Gao, C., Dai, H., Si, X., Liu, L., Wang, Z., Zheng, J.-H., Ke, Y., et al. (2023) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162023020073 · Cited by 2
Identification of Two Variants c.2697A > C and c.3305A > C in USP7 by Analysis of Whole-Exome Sequencing in Chinese Patients with Hao-Fountain Syndrome
Sun, M., Li, Q., Zhang, Y., Cai, Y., Dong, Y., Shu, J., Li, D., & Cai, C. (2024) · Global Medical Genetics · doi:10.1055/s-0043-1778089 · Cited by 2
Deubiquitylase ubiquitin-specific protease 7 plays a crucial role in the lineage differentiation of preimplantation blastocysts
Yu, T., Zhao, X., Tang, Y., Zhang, Y., Ji, B., Song, W., & Su, J. (2024) · Biology of Reproduction · doi:10.1093/biolre/ioae034 · Cited by 2
Designer polyQ fusion proteins sequester USP7/HDM2 for modulating P53 functionality
Zhang, X., Yue, H.-W., Liu, Y., Wang, J., Duan, H.-T., Liu, Y.-H., Jiang, L., & Hu, H. (2025) · iScience · doi:10.1016/j.isci.2025.112025 · Cited by 3
Roles of deubiquitinases in urologic cancers (Review)
Wu, L., Wang, J., Chai, L., Chen, J., & Jin, X. (2024) · Oncology Letters · doi:10.3892/ol.2024.14743 · Cited by 3
Methods to Study PTEN in Mitochondria and Endoplasmic Reticulum
Missiroli, S., Morganti, C., Giorgi, C., & Pinton, P. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3299-3_13 · Cited by 2
Ubiquitin-Specific Protease USP7
Faesen, A. C., Sixma, T. K., & Everett, R. D. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382219-2.00463-4 · Cited by 2
Dramatic impact of partial loss of PTEN function on tumorigenesis and progression of prostate cancer
Koita, M., Sosse, S. A., Abumsimir, B., Mahasneh, I. A., Mrabti, M., Laraqui, A., & Ennaji, M. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85496-2.00015-4 · Cited by 2
Ubiquitin Mediated Posttranslational Modification of Proteins Involved in Various Signaling Diseases
LAVANYA, V. A., Jamal, S., & Ahmed, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811913-6.00005-9 · Cited by 2
Dual-Specificity Protein Kinases
Thiriet, M. (2012) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-1-4614-4370-4_7 · Cited by 2
S18-phosphorylation of USP7 regulates interaction with TCEAL4 that defines specific complexes and potentially distinct functionsPreprint
Querques, F., Darling, S., Cheetham‐Wilkinson, I. J., Kim, R. Q., Hapangama, D. K., Sixma, T. K., & Coulson, J. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.07.451439 · Cited by 2
Deubiquitinase processing of a non-natural linkage of ubiquitinated-PTEN
Iwase, R., Maisonet, I. J., Lee, K., Buhrlage, S. J., & Cole, P. A. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108223 · Cited by 1
Computational Splicing Analysis of Transcriptomic Data Reveals Sulforaphane Modulation of Alternative mRNA Splicing of DNA Repair Genes in Differentiated SH-SY5Y Neurons
Lui, M., Chiricosta, L., Iori, R., Mazzon, E., Minuti, A., & Artimagnella, O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178187 · Cited by 1
Hypermethylated USP44 deubiquitinates SENP2: a critical mechanism in esophageal cancer progression and a new target for intervention
Wu, H., Zhang, X., Zhou, Z., Chen, K., Chen, J., Ma, C., Duan, J., Li, Y., & Chen, J.-W. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01958-1 · Cited by 1
In vivo study: Effectiveness and safety of reverse micelle EGCG as a cervical anticancer treatment
Rosita, N., Rosalina, L. A., Miatmoko, A., Erawati, T., Yusuf, H., & Plumeriastuti, H. (2025) · Journal of Research in Pharmacy · doi:10.12991/jrespharm.1798051 · Cited by 1
A novel antisense lncRNA, LPCRL, functions as a molecular scaffold for the USP15/MIB1 complex to promote primary cisplatin resistance and tumor progression in lung squamous cell carcinoma
Luo, P., Lu, D., Zhang, S., Dong, W., Fang, K., Yu, S., Bing, H., Zhu, M., Wang, Y., Jiang, X., et al. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03721-7 · Cited by 1
USP7 at PML Nuclear Bodies: A Protein Interaction Network Perspective
Silonov, S. A., Ведешкина, Е., Mokin, Y. I., Sukailo, D. A., Smirnov, E. Y., Reushev, V. A., Константинович, Т. К., Константинович, Т. К., & Fonin, A. V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27094106 · Cited by 1
A homologous cell membrane-coated peptide-based USP7 degrader enhances degradation efficiency and anti-tumor activity in gastric Cancer
Ma, C.-C., Jin, C., Guo, N.-J., Liu, H. F., Yin, Q.-G., Wang, Y., Liu, Y.-F., Zhang, Y., Wang, N., Lu, G., et al. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110067 · Cited by 1
ALK regulates macrophage polarization via the USP7/SOX9/MFAP2-mediated glycolytic pathway to promote neuroblastoma progression
Lai, C., 徐昆亭, Li, R., Chen, J., Zheng, Z., Zhong, M., Wang, Y., Shen, Z., & Chen, F. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112824 · Cited by 1
PML/RARA as the Master Driver of APL Pathogenesis and Therapy Response
de Thé, H., Zhu, J., Nasr, R., Ablain, J., & Lallemand-Breitenbach, V. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1393-0_23 · Cited by 1
Novel use of clinical drugs: Deubiquitinase inhibitor auranofin and disulfiram show synergistic anti-tumor effects in vitro and in vivo
Huang, H., Liao, Y., Liu, N., Cai, J., Wang, X., & Liu, J. (2016) · Cancer Cell & Microenvironment · doi:10.14800/ccm.1199 · Cited by 1
PiT1 : du transport de phosphate à la signalisation insulinique
Forand, A. (2017) · médecine/sciences · doi:10.1051/medsci/20173305007 · Cited by 1
Functional Relevance of Deubiquitinases in Life and Disease
Fraile, J. M., López-Otı́n, C., & Freije, J. M. P. (2017) · Springer eBooks · doi:10.1007/978-981-10-2513-6_16 · Cited by 1
Investigation of the expression levels of CDH1, FHIT, PTEN and TTPAL genes in colorectal tumors
Söylemez, E. S. A., Söylemez, Z., Çilekar, M., Arıkan, Y., Tokyol, Ç., Kenger, İ. H., & Solak, M. (2021) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2110-296 · Cited by 1
The Correlations between the Intensity of Histopathological Ubiquitin-Specific Protease 11 Staining and Progression of Prostate Cancer
Kim, J. H., Yang, H. J., Lee, K. W., Park, J. J., Lee, C.-H., Jeon, Y. S., Kim, J. H., Park, S., Song, S. J., Lee, J., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16121703 · Cited by 1
N-Myc Inhibition: Advances in Neuroblastoma Treatment
Hasan, M. K. (2017) · CellBio · doi:10.4236/cellbio.2017.63003 · Cited by 1
Molecular Genetics of APL
Mendez, L., Chen, M., & Pandolfi, P. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-64257-4_4 · Cited by 1
Self-citation
Conclusion
Thiriet, M. (2012) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-1-4614-4370-4_12 · Cited by 1
Tumor suppressors revival in CLL
Carrà, G., Taulli, R., & Morotti, A. (2017) · Aging · doi:10.18632/aging.101258 · Cited by 1
Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma
Franqui-Machin, R., Colgan, J. D., Henry, M. D., Quelle, D. E., Habelhah, H., & Zhan, F. (2018) · doi:10.17077/etd.4d8c6hku · Cited by 1
Loss of DAXX induces alternative lengthening of telomeres (ALT)-associated hallmarks in prostate cancer cells in a context-specific mannerPreprint
Mori, J., Da, J., Kim, J., Rizzo, A. J., Davis, C., Lanza, C., Brosnan‐Cashman, J. A., Meeker, A. K., Heaphy, C. M., & Graham, M. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.06.668744 · Cited by 1
Preamble to Cytoplasmic Protein Kinases
Thiriet, M. (2012) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-1-4614-4370-4_3
Synthetic Sickness with Molecularly Targeted Agents Against the EGFR Pathway
Stanley, J. A., & Yang, E. S.-H. (2015) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-14151-0_16
Characterising the role of the Cajal Body during a productive adenovirus infection
White, L. (2012) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Chromatin Dynamics During in vitro Differentiation of Human Urothelium
Fishwick, C. (2013) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
The effects of aberrant Wnt signalling on the murine intestinal stem cell compartment
Young, M. A. (2013) · ORCA Online Research @Cardiff (Cardiff University)
Characterization of the Molecular Signal Transduction Pathway of the Tyrosine Kinase Abl1 in Response to Genotoxic Stress
Plessl, T. (2013) · University of Vienna · doi:10.25365/thesis.27688
Hdm2 Small-Molecule Inhibitors For Therapeutic Intervention In B-Cell Lymphoma
Sosin, A. M. (2012) · Human Biology
Deubiquitinating Enzymes as Novel Targets for Cancer Therapies
Baek, K., Lim, K., & Park, J.-J. (2014) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-06752-0_15
Nuclear Subdomains and Cancer
Cann, K. L., Huang, S., & Dellaire, G. (2010) · Springer eBooks · doi:10.1007/978-90-481-9899-3_1
Rhesus rhadinovirus vIRF R12 disrupts the PML-nuclear body via proteasome-dependent protein degradation pathway
Gao, L. (2015) · OHSU Digital Commons · doi:10.6083/m44q7s0g
Cytosolic Protein Phosphatases
Thiriet, M. (2012) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-1-4614-4370-4_8
Other Major Types of Signaling Mediators
Thiriet, M. (2012) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-1-4614-4370-4_10
Structural Insight into the Mechanisms of Activation and Substrate Specificity of Human Deubiquitinating Enzyme USP7
Pozhidaeva, A. (2016) · OpenCommons at University of Connecticut (University of Connecticut)
Functions of Ubiquitin Specific Protease 7 (USP7) in Epstein-Barr Virus Infection and Associated Cancers
Sarkari, F. (2011) · TSpace (University of Toronto)
Insights into BTB-Cul3 Ubiquitin Ligases from the Structures of SPOP-Substrate Complexes
Zhuang, M. (2009) · doi:10.21007/etd.cghs.2009.0386
Avaliação proteômica das alterações no sistema ubiquitina proteassoma durante a transição epitélio-mesenquimal (EMT)
Silvestrini, V. C. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-30052019-162011

Authors: Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., & Pandolfi, P. P.
Affiliations: Beth Israel Deaconess Medical Center (US)
Corresponding author: Pandolfi, Pier Paolo
ORCID: Salmena, Leonardo
Carracedo, Arkaitz
Pandolfi, Pier Paolo
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2008-08-20
Volume: 455
Issue: 7214
Pages: 813-817
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature07290
PMC: PMC3398484
OpenAlex: W2162648910
Cited by: 548
References: 34
Citations by year: 2026: 15 · 2025: 27 · 2024: 22 · 2023: 35 · 2022: 25 · 2021: 37 · 2020: 43 · 2019: 40 · 2018: 33 · 2017: 39 · 2016: 34 · 2015: 36 · 2014: 32 · 2013: 27 · 2012: 31
FWCI: 9.86
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
Funders: European Molecular Biology Organization
National Institutes of Health
National Cancer Institute (R01CA082328, P50CA092629)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: PTEN, USP7, PML, nuclear localization, PML nuclear bodies, DAXX, PML-RARA fusion, acute promyelocytic leukemia, all-trans retinoic acid, arsenic trioxide, prostate cancer, tumor suppressor regulation, ubiquitination, nuclear-cytoplasmic trafficking
MeSH terms: Promyelocytic Leukemia Protein, Ubiquitin-Specific Peptidase 7, Animals, Cell Nucleus, Fibroblasts, Humans, Male, Nuclear Proteins, Prostatic Neoplasms, Transcription Factors, Tretinoin, Ubiquitins, Leukemia, Promyelocytic, Acute, Apoptosis, Molecular Chaperones, Active Transport, Cell Nucleus, Tumor Suppressor Proteins, Ubiquitin Thiolesterase, Cell Line, Tumor, Adaptor Proteins, Signal Transducing, PTEN Phosphohydrolase, Mice, Ubiquitination, Co-Repressor Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks